MedPath

Efficacy of Magnesium Sulfate as an Adjuvant in Erector Spinae Plane Block as an Anesthetic Post Operative After Modified Radical Mastectomy

Early Phase 1
Not yet recruiting
Conditions
ESPB, Mg Sulfate,Post Mastectomy
Interventions
Drug: Magnesium sulfate in erector spinae plane block
Registration Number
NCT05976464
Lead Sponsor
Assiut University
Brief Summary

efficacy of magnesium sulfate as an adjuvant in erector spinae plane block as an anesthetic post-operative after modified radical mastectomy

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
60
Inclusion Criteria
    1. ASA I-II. 2. Female patients aged 18-65 years. 3. Scheduled for a modified radical mastectomy with axillary dissection for breast cancer.
Exclusion Criteria
  1. ASA < II.

  2. more than 65 years old

  3. Patients with known allergies to the study drugs

  4. Skin infection at the site of needle puncture.

  5. Coagulopathy

  6. Drug or as that would interfere with perception and assessment of pain. 6. Uncooperative patients.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
erector spinae plane blockMagnesium sulfate in erector spinae plane blockUltrasound-guided Erector spinae plane (ESP) block will be done with the patient in a sitting position depending on the surgical site (lt. or Rt.) ESP block will be given using high-frequency linear u/s transducer, the probe is placed in longitudinal orientation lateral to the thoracic third and sixth spinous process, the erector spinae muscle, is identified from the surface, we will deposit 20 ml of 0.25% levobupivacaine into interfacial plane below erector spinae muscle.
magnesium sulfate as an adjuvant in erector spinae plane blockMagnesium sulfate in erector spinae plane blockUltrasound-guided Erector spinae plane (ESP) block will be done with the patient in a sitting position depending on surgical site (lt. or Rt.) ESP block will be given using high-frequency linear u/s transducer, the probe is placed in longitudinal orientation lateral to the thoracic third and sixth spinous process, the erector spinae muscle, is identified from the surface, we will deposit 20 ml of 0.25% levobupivacaine and magnesium sulfate into interfacial plane below erector spinae muscle.
Primary Outcome Measures
NameTimeMethod
- The primary outcome measure in this study will be the total dose of morphine consumption during the 24 hour Postoperatively.Up to 24 hour
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath